Cardiologists near Hackensack, NJ

Care Philosophy: Dr. Fuster focuses on preventative medicine globally. He has created the SHE Foundation (Science, Health and Education) with the aim of improving total health in the population, especially young people. Dr. Fuster serves as an international advisor on Sesame Workshop's Global Health Initiative. The goal of the initiative is to measure health improvements in children and build global partnerships to address their critical health issues.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Noah Moss, MD is an Advanced Heart Failure /amp Transplant Cardiology Specialist who practices in New York, NY. He is 42 years old and has been practicing for 16 years. Dr. Noah Moss, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Care Philosophy: Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Care Philosophy: Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Jeffrey W. Moses, MD, is a renowned interventional cardiologist and Professor of Medicine at Columbia University Medical Center. Dr. Moses serves as the Director of Interventional Cardiovascular Therapeutics at Columbia Interventional Cardiovascular Care and the Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY.With a track record of over 18,000 interventional procedures, Dr. Moses is an accomplished researcher. He has served as a lead investigator for numerous national and international clinical studies and authored over 600 publications, many focusing on the effectiveness and safety of coronary stent placement. Notably, his pivotal role in a 2002 clinical trial resulted in the first U.S. FDA approval of a drug-coated stent, now widely used in American interventional procedures.Dr. Moses contributed to the Executive Committee of the PARTNER trial, which introduced the first transcatheter aortic valve for clinical use in the U.S. A pioneer in various approaches, including minimally invasive surgery, angioplasty, gene therapy, and novel imaging technologies, he extends the application of interventional cardiovascular procedures. He is a fellow in multiple professional societies and serves on the editorial board as a reviewer for numerous peer-reviewed journals.Dr. Moses serves on the Board of the Cardiovascular Research Foundation (CRF); and continues to make formidable contributions in the areas of clinical research and educational activities in interventional vascular therapy.Before his tenure at Columbia, Dr. Moses held a professorship in Clinical Medicine at New York University School of Medicine. He also played key roles at The New York Hospital (now NewYork-Presbyterian), where he served as the Associate Director of the Adult Cardiac Catheterization Laboratory and Director of Clinical Electrophysiology.Dr. Moses completed medical school at the University of Pennsylvania School of Medicine and his internship, residency, and fellowship in Cardiology at the Presbyterian University of Pennsylvania Medical Center.

Biography: Dr. Jonathan Halperin, MD is a Cardiology Specialist who practices in New York, NY. He is 76 years old and has been practicing for 50 years. Dr. Jonathan Halperin, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Alan Hecht, MD is an Internist who practices in New York, NY. He is 67 years old and has been practicing for 44 years. Dr. Alan Hecht, MD is affiliated with Mount Sinai Hospital.

Biography: Stefano Ravalli, MD is a cardiologist at Columbia University Medical Center/NewYork-Presbyterian Hospital. Dr. Ravalli's areas of expertise include coronary artery disease, hypertension, cardiac imaging, congestive heart failure and valvular heart disease. Dr. Ravalli is board certified in cardiovascular disease and is a Fellow of the American College of Cardiology. Dr. Ravalli received his medical degree from the University of Rome La Sapienza, where he graduated Summa cum laude. He completed his residency and internship at Beth Israel Medical Center in New York, cardiology and heart failure/transplant cardiology fellowships at Columbia University Medical Center. Dr. Ravalli has been named as a New York Super Doctor and US News & World Report's Best Doctors of America. Dr. Ravalli is an active preceptor at Columbia for medical student, residents and fellows and has authored more than 40 manuscripts and abstracts. Dr. Ravalli is a member of the ColumbiaDoctors Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension. He sees patients at ColumbiaDoctors Midtown and Columbia University Medical Center in Washington Heights, New York.

Biography: Dr. Hasan Garan, MD is a Cardiology Specialist who practices in New York, NY. He is 79 years old and has been practicing for 51 years. Dr. Hasan Garan, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Robert J. Sommer, MD, is an accomplished medical professional and Associate Professor of Medicine at Columbia University Irving Medical Center. He currently serves as the Director of Invasive Adult Congenital Heart Disease at Columbia's Interventional Cardiovascular Care program, based in Columbia University Irving Medical Center/NewYork-Presbyterian.Dr. Sommer's expertise lies in the areas of pediatric cardiology, adult congenital heart disease, and interventional cardiology. He is Board-certified in both Pediatric and Adult Congenital Heart Disease. He completed his training in pediatrics and pediatric cardiology at Mount Sinai Hospital in New York City and Boston Children's Hospital in Boston. CLINICAL WORKIn 1991, Dr. Sommer made significant contributions to the field by establishing the first comprehensive pediatric interventional catheterization laboratory in New York City. In 1999, he launched his own practice and redirected his focus towards the growing population of adult patients with congenital heart disease. Dr. Sommer's joined the faculty at Columbia University Irving Medical Center in 2005.Dr. Sommer has expertise in a diverse range of congenital and structural heart interventions. Dr. Sommer directs the Left Atrial Appendage Closure Team at Columbia, having participated in the PREVAIL Trial, the CAP2 registry, and the CHAMPION-AF Trials using the Watchman Device, as well as the Amulet Device Pivotal and Conformal Device Feasibility Trial. In addition to diagnostic catheterizations in complex congenital heart disease, he performs over 200 atrial septal defect and patent foramen ovale (PFO) closures and over 100 left atrial appendage closures annually. He has decades of experience in closing patent ductus arteriosus and ventricular septal defects, as well as, stenting coarctation of the aorta. Currently, Dr. Sommer serves as the national cardiology principal investigator for the GORE RELIEF clinical study to evaluate patent foramen ovale (PFO) closure for migraine headache relief using a device called the GORE CARDIOFORM Septal Occlude.Dr. Sommer collaborates closely with his Pediatric Cardiology colleagues at Columbia performing transcatheter pulmonary valve replacements in the congenital population. Together, with Barbara Robbins, NP, he provides primary cardiac care to a population of more than 300 pediatric and adult patients with congenital heart disease. Jointly, they manage more than 1500 office visits annually.

Biography: Christopher Irobunda, MD, is an Associate Professor at CUMC and an interventionalist. He is also Vice Chair of the Faculty Development focusing on Diversity, Equity & Inclusion within the Department of Medicine. He trained as a general and interventional cardiologist. Dr. Irobunda has been a full-time faculty since 2003. He obtained his MD/PhD in the Medical Scientist Training Program at the Albert Einstein College of Medicine in the Bronx, NY. His PhD was in Molecular Pharmacology, specifically on the cyclic Adenosine MonoPhosphate/beta-adrenergic signal transduction system. He subsequently completed an internship and residency in internal medicine at New York University Medical Center, followed by his General and Interventional Cardiology Fellowship here at Columbia University Medical Center. After completing his medical training and research study, he shifted his concentration to patient care and the education of aspiring young physicians. Dr. Irobunda is ardently dedicated to uncompromised patient care and teaching. His primary focus is individualized patient care and patient advocacy. Given his training as a medical scientist, it is hardly surprising that he is a keen diagnostician. He has a penchant for complex cardiac issues and other medical problems that can sometimes mask or aggravate the cardiac disease. His aptitude for unraveling these medical conundrums has led to medical diagnoses for patients who have come to him for second and even third opinions. However, above all else, his true genius is his ability to relate to his patients with intelligence, curiosity, patience, compassion, and humor. His ability to waylay even the most apprehensive of patients with his aura of reassurance and understanding has garnered him a continually growing medical practice. Again and again, individuals will refer family members and friends because of the empathy and level of care constantly provided. Indeed, his unceasing diligence has led him to become a physician member of Columbia University Medical Centers Patient Facilitated Services, an organization directed at patient satisfaction and outreach. Dr. Irobunda has also been the primary cardiologist for patients undergoing liver transplant evaluations at New York Presbyterian since 2004. When not in his private practice, he takes great pleasure in helping train the new influx of physicians in the only ethical way to practice medicinepatient-centered care. Dr. Irobunda has been a Supervisor and Attending Faculty for the Fundamentals of Clinical Medicine for First Year Medical Students at Columbia University College of Physicians and Surgeons since 2011, a program that endeavors to instill exceptional patient-doctor communication and trust. He encourages future medical practitioners to listen to the patient and learn to interpret and analyze the information being imported; to realize that the seemingly insignificant details sometimes lead to the culprit of an individual's illness. He has been a lecturer with International Postgraduate Organization for Knowledgetransfer, Research, and Teaching Excellent Students (IPOKRaTES) in Europe. IPOKRaTES offers opportunities for physicians from a plethora of countries to observe and gain instruction regarding differing methods in patient care practices. Since the summer of 2012, Dr. Irobunda has become involved in New York Presbyterian Hospital's Lange Youth Program, which seeks to prepare and enumerate the rigors of medical school for high school students. Dr. Irobunda is active in numerous community outreach organizations-Abyssian Baptist Church (NY), JP Morgan Chase Employee Education Program, Riverside Church Seniors, and Sister to Sister: The Women's Heart Health Foundation, to name a few. He seeks to educate the public on cardiovascular issues and ways to make everyday lifestyle modifications to help reduce these risks. In addition to being an interventional cardiologist who can perform angioplasties and stent placements, he emphasizes the prevention and treatment of heart disease through diet, exercise, and medical therapy.